7th Aug 2007 14:03
Vernalis PLC07 August 2007 VERNALIS PLC ANNUAL INFORMATION UPDATE As required under Prospectus Rule 5.2, and following publication of the AnnualReport on 20th April 2007, the following summarises the information anddocuments published or made available to the public by the Company between 24thMay 2006 and 6th August 2007 inclusive. This Annual Information Update is also being made available on the Investorssection of the Company's website at www.vernalis.com. The information referred to in this Annual Information Update was correct at thetime it was published but some information may now be out of date. 1. Announcements made via a Regulatory Information Service ("RIS") Date Description of Contents of Announcement24/05/2006 Results of the AGM19/06/2006 Investor Conferences05/07/2006 Holding(s) in Company20/07/2006 sNDA for Frova28/07/2006 Additional Listing03/08/2006 Phase IIa Trial of V338103/08/2006 Holding(s) in Company23/08/2006 Notice of Results12/09/2006 Interim Results - Part 112/09/2006 Interim Results - Part 213/09/2006 Director/PDMR Shareholding20/09/2006 Filing of Frova(R)20/09/2006 UBS Global Life Sciences Conf02/11/2006 Global Health Care Conference20/11/2006 Oncology Hsp90 Programme21/11/2006 Piper Jaffray Healthcare Conf11/12/2006 Phase I Trial of V2434320/12/2006 Appointment of Ian Clark20/12/2006 Total Voting Rights29/01/2007 Notice of Results29/01/2007 Holding(s) in Company12/03/2007 Preliminary Results - Part 112/03/2007 Preliminary Results - Part 212/03/2007 Preliminary Results - Part 312/03/2007 Frova(R) in France16/03/2007 PDUFA date for Frova(R) sNDA22/03/2007 Holding(s) in Company20/04/2007 Holding(s) in Company24/04/2007 Nasdaq Stock Market08/05/2007 Biogen Idec and Vernalis17/05/2007 Drug Discovery Collaboration23/05/2007 AGM Statement04/06/2007 Director's Share Dealing06/06/2007 Director/PDMR Shareholding11/06/2007 Frova Phase III Data16/07/2007 Phase IIa Trial of V338102/08/2007 Holdings(s) in Company All of the above UK regulatory announcements have been made via a RIS and can beobtained from the London Stock Exchange's website at www.londonstockexchange.comor the Company's website at www.vernalis.com. 2. Documents filed at Companies House All the documents listed below were filed with the Registrar of Companies inEngland and Wales on or around the dates indicated. Date Document Type31/05/2006 Annual Report and Accounts31/05/2006 Memorandum and Articles of Association03/06/2006 Annual General Meeting Resolutions04/08/2006 Form 88(2) - Return of Allotment of Shares05/08/2006 Form 288b - Resignation of Director18/08/2006 Form 363s - Annual Return17/01/2007 Form 288a - Appointment of Director25/05/2007 Annual Report and Accounts30/05/2007 Annual General Meeting Resolutions Copies of the above documents, filed with the Registrar of Companies, can beobtained from the Companies House website at www.companieshouse.gov.uk, or canbe obtained from Companies House, Crown Way, Cardiff, CF14 3UZ. 3. Documents published or sent to Shareholders or filed with the UK ListingAuthority or submitted to the FSA All the documents below were submitted to the FSA/UKLA on or around the datesindicated. Date Document20/07/2006 Application for Admission of Securities to the Official List20/07/2006 Form 1 - Application for Admission of Securities to Trading12/09/2006 Interim Report12/03/2007 Preliminary Report20/04/2007 Annual Report and Circular/Notice of Meeting Certain documents submitted to the FSA can be viewed at the Document ViewingFacility situated at The Financial Services Authority, 25 The North Colonnade,Canary Wharf, London, E14 5HS. The Notice of Annual General Meeting and Annual, Interim and Preliminary Reportsare also available via the Investors section of the Company's website atwww.vernalis.com. 4. Documents lodged with the Securities and Exchange Commission The documents listed below were filed with the SEC on or around the datesindicated. Date Document11/05/2006 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)29/06/2006 20-F Annual and transition report of foreign private issuers (Sections 13 or 15(d))13/07/2006 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)21/08/2006 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)05/09/2006 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)29/09/2006 Correspondence02/10/2006 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)27/10/2006 SEC Generated Letter16/11/2006 SEC Generated Letter30/11/2006 Correspondence08/12/2006 SEC Generated Letter11/12/2006 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)08/01/2007 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)07/02/2007 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)16/02/2007 Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals04/04/2007 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)24/04/2007 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)04/05/2007 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities04/06/2007 Form 6-K - Report of foreign issuer (Rules 13a-16 and 15d-16)04/06/2007 Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments04/06/2007 Form 15F-12G - Securities registration termination of foreign private issuers (Section 12(g))04/06/2007 Form F-6 POS - Post-effective amendments for immediately effective filing Copies of the above documents are available for viewing on the Securities andExchange Commission website at www.sec.gov. 5. Further Information Further information about Vernalis plc can be found on our website atwww.vernalis.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Vernalis PLC